Ask three NAD+ providers how fast their therapy works and the answers do not line up. One describes a difference within minutes of an infusion, another puts injection onset at hours to days, and a third describes noticeable change within days, mostly in people who were significantly depleted to begin with. None of that comes from controlled measurement. It is reported experience, and that distinction matters more than usual when you are trying to fit a treatment into a schedule built around flights and client meetings, because how fast something is supposed to work determines how many sessions you are willing to chase across how many cities.
For a man who spends half his month on the road, the useful question is not which delivery method is stronger in theory but which one survives contact with an itinerary. NAD+ injections and NAD+ IV therapy differ in session length, absorption, dosing frequency, prescription logistics, and cost per dose, and every one of those differences gets sharper once treatment has to travel with you. The dollar figures below are general market ranges published by third-party providers, not the pricing of any one clinic, and reported means reported rather than proven.
Getting NAD+ Into a Business Trip Without Losing an Afternoon
Session length is the first place these two methods separate, and it is not a close call. Published provider comparisons put NAD+ IV therapy at one to four hours per infusion, delivered through a line that requires clinic infusion equipment and staff monitoring for the duration of the session. A NAD+ injection, given subcutaneously or intramuscularly, takes five to ten minutes per dose and can either be self-administered or handled in a short clinic visit. On time commitment alone, the three delivery methods land in very different places:
- Oral NAD+ supplements: seconds, taken daily at home, no appointment involved
- NAD+ injections: five to ten minutes per dose, self-injectable or a brief clinic visit
- NAD+ IV therapy: one to four hours per infusion, requiring clinic equipment and supervision
What the longer session buys is absorption. The same comparisons put IV bioavailability at roughly 100 percent, against moderate to high for injections and low to moderate for oral forms. So the infusion delivers the most complete reported availability and charges you an afternoon for it. That is the entire tension for a traveling professional. A one to four hour block is difficult to place inside a trip where you land, work, and fly out again, and it has to be booked in a city where a clinic can take you. Five to ten minutes fits into almost any gap. The real decision is whether the absorption difference is worth the calendar difference for your situation, which is a question for a prescribing physician rather than something to settle from a comparison table.
Why Digestion Determines How Much NAD+ Actually Reaches Your Cells
Those bioavailability figures are not arbitrary. They track what happens to NAD+ before it reaches circulation. Anything swallowed passes through the gut and then through liver metabolism, and that first pass breaks down or diverts a meaningful share of the dose, which is why oral NAD+ carries the lowest reported bioavailability of the three routes. Subcutaneous and intramuscular injections skip gut digestion entirely, depositing the dose into tissue where it moves into the bloodstream over a short period, and the reported absorption sits in the moderate to high range as a result. An IV skips both stages, putting NAD+ straight into the bloodstream. One review comparing NAD+ injections against supplements describes the mechanism plainly: IV infusions push NAD+ into circulation rapidly, which is why clinics offering them report faster, more noticeable effects.
Oral NAD+ and its precursors, NMN and NR, are best understood as a third option rather than a substitute for either injectable route. Their practical role is daily maintenance in the stretches between higher-dose sessions, which is a genuinely useful role when your access to a clinic is intermittent. A bottle of capsules crosses time zones more easily than a vial or an infusion appointment does. What it does not do is match the reported delivery of an injection or an infusion, so treating it as a swap rather than a bridge sets up the wrong expectation.
Onset Claims That Don't Line Up Across Providers
Sort the published onset claims side by side and the conflict is obvious. One provider comparison table lists injection onset as hours to days and IV onset as during or shortly after the session. Another comparison of injections and IV therapy is more aggressive about speed, stating that Many people report feeling a difference within hours, sometimes even minutes. A third frames improvement in energy and mental clarity as arriving within days, and specifically notes that this applies most to people who were significantly NAD+ depleted before starting. Those are three different timeframes for the same compound.
The common thread is that all of them are reports, not measurements. Nothing in the available material tracks onset under controlled conditions. The two peer-reviewed studies that get cited in this space do not close the gap either: a 2018 Nature Medicine study examined NMN supplementation and muscle NAD+ metabolism in postmenopausal women with prediabetes, and a Cell Reports study looked at NAD+ precursors, neuroinflammation, and cognition in aged mice. Both tested oral precursors in populations that are not working-age men, and neither measured injectable or IV onset. If you want something closer to an individual answer, baseline and follow-up numbers from advanced lab testing for hormones will tell you more about your own starting point than any provider's onset estimate will.
Loading Phase Protocols Don't Bend Easily to a Moving Itinerary
Frequency is where the two methods diverge in a way that a travel calendar feels immediately. Typical injection protocols run two to three times per week. Typical IV protocols run weekly to monthly. Read quickly, that makes IV look like the lighter scheduling burden, and for a maintenance rhythm it often is. The complication sits at the front end. IV programs frequently open with what providers call a loading phase, a cluster of sessions compressed into a short window, and one commonly described version involves four treatments within ten days.
A protocol like that assumes you can return to the same provider four separate times inside a week and a half. That assumption holds for someone anchored to one metro area. It does not hold for a man who is in three cities over the same ten days. What the available material does not address is what happens when the assumption fails: whether a loading phase can be stretched, split between clinics, or restarted, and whether the intended benefit still applies if the sessions drift apart. That question is genuinely unsettled and appears to vary by provider, which makes it something to raise before you book the first infusion rather than after you miss the third. Injections carry a milder version of the same problem. Two to three doses a week is a rhythm you can maintain on the road if you are carrying your own supply, and a rhythm you will break if every dose requires finding a clinic in an unfamiliar city.
Take-Home NAD+ Injections Across Airport Security and State Lines
Self-injectable NAD+ requires a prescription in the United States. That single fact drives most of the travel logistics, and the available material stops short of resolving the questions that follow from it. Whether a prescription written by one provider, or in one state, transfers for filling or use somewhere else is not addressed in the sourced material, and prescribing rules are jurisdictional by nature, so this is best treated as unsettled and provider-specific rather than assumed. The same gap covers the practical handling questions. How a take-home vial should be stored or refrigerated while you are moving between hotels, and whether it can be carried through airport security, are not answered in the available material either.
None of that makes take-home injections impractical. It makes them a question to settle with your prescriber in advance, in writing, before you pack. It is the same supervision-versus-convenience tradeoff that shows up when men weigh clinic testosterone injections versus at-home TRT programs, where the convenience of dosing on your own schedule is only as sound as the oversight behind it. Across every one of these scenarios, the constant is not the city where a dose gets administered but the physician relationship that issued the prescription and is monitoring what happens next.
Total Cost of Staying Consistent Across Multiple Cities
Published market ranges put real distance between the three methods. Oral NAD+ supplements run roughly $40 to $120 per month. Injections run about $25 to $75 per dose, which lands near $100 to $300 per month at typical frequency. IV therapy runs $150 to $500 or more per session, or roughly $300 to $1,000 and up per month. Insurance does not cover any of the three delivery methods according to the same source, so every one of those figures is out of pocket every time.
That last point compounds in a way single-location patients rarely experience. A man booking infusions in three different cities pays the full per-session rate at each one, without the continuity a home clinic might build into an ongoing plan, and without the option of absorbing a missed week into a standing schedule. Travel also adds cost that never shows up in a treatment price list, in the form of the hours an infusion consumes and the trips scheduled around clinic availability instead of work. Injections change that math because the per-dose figure travels with you rather than resetting at every stop. Oral maintenance changes it further, which is exactly why the bridge role is worth pricing out alongside the higher-dose options rather than after them.
Verdict by Travel Pattern
If you fly frequently for short trips, injections are the more realistic option, because portability and a five to ten minute administration window are the two variables travel punishes hardest. That verdict is entirely contingent on having a physician-issued prescription and clear guidance on handling it away from home. If you are based mainly in one metro and travel occasionally, IV therapy becomes reasonable, since you can block a one to four hour session and you get the near-complete reported absorption that comes with direct delivery into the bloodstream. If your travel is light and intermittent, oral NMN or NR is a defensible maintenance bridge between higher-dose sessions, understood as a supplement to a plan rather than the plan itself.
What does not change across those three cases is the value of physician-guided care behind the decision. Fatigue, mental fog, and flat drive are the same complaints that send men to look into low testosterone in the first place, including the separate question of whether low testosterone can cause ED, and sorting that out calls for testing rather than guessing at a delivery method. Boston Vitality specializes in testosterone optimization, ED treatment, medical weight loss, and performance restoration, with treatment plans built around your symptoms, labs, lifestyle, and goals, and with testing, diagnosis, and follow-up monitoring included in that care. NAD+ therapy is one of the topics covered on the Boston Vitality men's health blog alongside TRT and long-term health optimization. For men weighing personalized TRT clinic services or looking for a hormone specialist for men in Massachusetts, the ongoing relationship is what turns isolated sessions into something you can actually maintain from the road. Schedule your consultation and start there.
TL;DR: For men who travel frequently, NAD+ injections are faster to administer and easier to fit around flights and meetings, while IV therapy requires longer sessions and more planning but may suit less time-pressed schedules, so the right choice depends on session length, dosing frequency, and cost per dose rather than which method is theoretically stronger.